# 3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

> **NCT05475015** · — · RECRUITING · sponsor: **Shengjing Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Cirrhosis, Liver
- Portal Hypertension
- Advanced Chronic Liver Disease

## Interventions

- **DEVICE:** 3D-MRE
- **DEVICE:** HVPG

## Key facts

- **NCT ID:** NCT05475015
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-16
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05475015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05475015, "3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05475015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*